Skip to main content
Humedix Co., Ltd. logo

Humedix Co., Ltd. — Investor Relations & Filings

Ticker · 200670 ISIN · KR7200670008 KO Manufacturing
Filings indexed 317 across all filing types
Latest filing 2022-05-16 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 200670

Humedix Co., Ltd. is a healthcare company that develops and manufactures biological and pharmaceutical products focused on human health and beauty. The company specializes in hyaluronic acid-based applications, producing medical devices such as dermal fillers and arthritis treatments. Its portfolio also includes prescription medicines, active pharmaceutical ingredients (APIs), and functional cosmetics. Additionally, Humedix offers Contract Manufacturing Organization (CMO) services within the healthcare sector.

Recent filings

Filing Released Lang Actions
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Humedix' (주식회사 휴메딕스) covering the period from January 1, 2022, to March 31, 2022. It contains detailed financial information, business operations, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details changes in share ownership by a major shareholder and their special related parties, including specific transaction dates, methods (e.g., open market sale), and updated shareholding percentages. This fits the definition of a 'Major Shareholding Notification' (MRQ).
2022-04-29 Korean
[기재정정]현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a regulatory filing from Humedix regarding a 'Cash/In-kind Dividend Decision' (현금ㆍ현물배당 결정). It details the dividend amount per share, payment date, and shareholder meeting approval status. This falls under the category of dividend announcements.
2022-04-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the share ownership of Humedix by Huons Global and its special related parties, including changes in shareholding due to executive appointments and resignations. This type of filing is a standard regulatory requirement for major shareholders to disclose their holdings and is classified as a Major Shareholding Notification.
2022-04-07 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB) due to a decline in the market price of the underlying stock. This type of disclosure is a standard corporate action related to capital structure and financing instruments. Among the provided categories, 'CAP' (Capital/Financing Update) is the most appropriate classification as it covers updates on financing activities and capital structure changes, including adjustments to convertible debt terms.
2022-04-06 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Shareholders' Meeting (AGM) for the company 'Humedix'. It details the outcomes of various agenda items, including the approval of financial statements, dividend declarations, and the election of directors and audit committee members. Since it provides the official results of the shareholder votes at the Annual General Meeting, it falls under the 'Declaration of Voting Results & Voting Rights Announcements' category.
2022-03-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.